From March 3-4, Medtrade 2026 kicked off at the Phoenix Convention Center in Phoenix, AZ, USA. ChoiceMMed made a powerful debut at the event, showcasing its latest lineup of innovative products. At this premier industry gathering,which attracted over 20,000 professional visitors, the company not only demonstrated the strength of ChoiceMMed's manufacturing excellence, but also offered a compelling vision of the intelligent future of home healthcare.

Responding to the growing demand for chronic disease management in North America, ChoiceMMed has developed a versatile range of portable and intelligent solutions tailored for various home environments. At its booth, the company presented a comprehensive oximetry ecosystem, including pediatric, fingertip, handheld, and wrist-worn models designed to meet the needs of diverse users. ChoiceMMed's medical-grade pulse oximeters became a center of attention at the exhibition, attracting numerous professional visitors with their non-invasive, precise SpO₂ monitoring suitable for all skin tones, as well as pulse rate and respiratory rate detection and arterial stiffness risk warning. Representatives from rehabilitation agencies and home care companies praised the devices, noting that such precision and intelligent functionality will significantly enhance the efficiency and safety of chronic disease management at home.

From precision monitoring to smart intervention, and from portable devices to connected data ecosystems, ChoiceMMed is breaking down the barriers between home and hospital through integrated technology. Backed by the full industrial chain support of its parent company, Tianjin Chasesun Pharmaceutical Co., Ltd., ChoiceMMed continues to advance in core technology and digital manufacturing. By embedding professional medical technology into everyday life, the company is delivering warmer, more personalized health protection to users around the world.